About this Journal Submit a Manuscript Table of Contents
Parkinson’s Disease
Volume 2014 (2014), Article ID 426976, 8 pages
http://dx.doi.org/10.1155/2014/426976
Clinical Study

Mortality in Levodopa-Treated Parkinson's Disease

1Movement Disorders Program, Department of Neurology, Medical College of Georgia, Georgia Regents University, 1429 Harper Street HF-1154, Augusta, GA 30912, USA
2Movement Disorders Division, Department of Neurology, University of Virginia, P.O. Box 800394, Charlottesville, VA 22908, USA
3Parkinson’s & Movement Disorders Center, Department of Neurology, Virginia Commonwealth University, 6605 West Broad Street, First Floor, Suite C Richmond, VA 23230, USA
4Clinical Development, Forest Laboratories, Inc., Jersey City, NJ, USA

Received 2 September 2013; Revised 13 November 2013; Accepted 14 November 2013; Published 28 January 2014

Academic Editor: Jan O. Aasly

Copyright © 2014 John C. Morgan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

John C. Morgan, Lillian J. Currie, Madaline B. Harrison, James P. Bennett Jr., Joel M. Trugman, and G. Frederick Wooten, “Mortality in Levodopa-Treated Parkinson's Disease,” Parkinson’s Disease, vol. 2014, Article ID 426976, 8 pages, 2014. doi:10.1155/2014/426976